Amy Comstock Rick Joins Leavitt Partners, an HMA Company
Amy Comstock Rick, former president and chief executive officer (CEO) of the Food and Drug Law Institute (FDLI), joined Leavitt Partners, an HMA Company as a principal on March 20. Rick has over 30 years of experience leading organizations, executing strategy, transforming organizational culture, building consensus, and advocating policies across constituencies. “Amy is widely respected … Read more
New white paper from Medicines Development Modernization Initiative
Data science and digital health in clinical development and operations: impact, challenges, and calls to action for the drug development ecosystem In this paper, the Medicines Development Modernization Initiative discuss how three medicines development tools (MDTs) – artificial intelligence (AI) and machine learning (ML) algorithms, digital health tools (DHTs), and augmentation of randomized controlled trial … Read more
Supporting Pharmacy Data Interoperability: An Imperative for Patient Access and Outcomes
Pharmacy provision of clinical services is important to patient access and outcomes. As patients access more services from pharmacies, the data interoperability of those pharmacies becomes more important to the healthcare system at-large. Pharmacy teams’ ability to provide optimal care and meaningfully contribute to the value-based care transformation depends on their ability to access and … Read more
Leavitt Partners Report Identifies Strategies to Improve Pharmacy Data Interoperability
Today, Leavitt Partners, an HMA Company released a report outlining steps federal and state policymakers, technology and electronic health record (EHR) companies, health plans, pharmacies, and other healthcare providers can take to strengthen pharmacy data interoperability. As patients access more services from pharmacies, the data interoperability of those pharmacies becomes increasingly important to patients and … Read more
CARIN Alliance and HHS Release Digital Identity Federation Report about their Test Proof of Concept
Washington, D.C., March 22, 2023 — The CARIN Alliance, a multi-sector collaborative of healthcare and other stakeholders working to advance the consumer-directed exchange of health information released a report today that lays the foundation for how individuals can voluntarily digital identity proof themselves once and use that same digital credential with multiple data holders of … Read more
CMS Targets Value-Based Purchasing, Drug Costs to Reduce Spending
A RevCycleIntelligence article entitled “CMS Targets Value-Based Purchasing, Drug Costs to Reduce Spending” references the Leavitt Partners “Accountable Care Organizations and Risk-Based Payment Arrangements: Strong Preference for Upside-Only Contracts” white paper. The article states, “About 61 percent of ACO contracts contain only upside financial risk, meaning organizations do not have to repay financial losses, a … Read more
Digital Health Landscape
Digital health has experienced a rapid transformation in the last two years since the beginning of the COVID-19 pandemic, dramatically shifting how care is delivered to patients. To better understand the rapid changes occurring in the industry and capitalize on future market movements, Leavitt Partners has created a digital health taxonomy and standardized definitions, along with robust market segmentations and … Read more
The Role of ACOs in Advancing Health Equity: A Comparison Between MSSP and ACO REACH
CMS’s recent integration of health equity into its new and existing value-based payment (VBP) programs (as outlined below) signals a strong commitment to equitable care delivery. We expect health equity to be incorporated into additional federal programs and for private payers to follow CMS’s example in designing their own plans for managing the diverse needs … Read more
New White Paper: The Impact of the 340B Program on Drug Prices Charged by Manufacturers and Covered Entities
Leavitt Partners examined publicly available resources to determine the 340B Drug Pricing Program’s (340B) impact on drug prices charged by both covered entities and pharmaceutical manufacturers. To answer these questions, Leavitt Partners undertook a comprehensive literature review of publicly available governmental reports, peer-reviewed journal articles, white papers, news articles, and other publicly available sources to … Read more